• This record comes from PubMed

Injectable Extracellular Matrix Hydrogels as Scaffolds for Spinal Cord Injury Repair

. 2016 Feb ; 22 (3-4) : 306-17.

Language English Country United States Media print

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/pmid26729284

Restoration of lost neuronal function after spinal cord injury (SCI) still remains a big challenge for current medicine. One important repair strategy is bridging the SCI lesion with a supportive and stimulatory milieu that would enable axonal rewiring. Injectable extracellular matrix (ECM)-derived hydrogels have been recently reported to have neurotrophic potential in vitro. In this study, we evaluated the presumed neuroregenerative properties of ECM hydrogels in vivo in the acute model of SCI. ECM hydrogels were prepared by decellularization of porcine spinal cord (SC) or porcine urinary bladder (UB), and injected into a spinal cord hemisection cavity. Histological analysis and real-time qPCR were performed at 2, 4, and 8 weeks postinjection. Both types of hydrogels integrated into the lesion and stimulated neovascularization and axonal ingrowth into the lesion. On the other hand, massive infiltration of macrophages into the lesion and rapid hydrogel degradation did not prevent cyst formation, which progressively developed over 8 weeks. No significant differences were found between SC-ECM and UB-ECM. Gene expression analysis revealed significant downregulation of genes related to immune response and inflammation in both hydrogel types at 2 weeks post SCI. A combination of human mesenchymal stem cells with SC-ECM did not further promote ingrowth of axons and blood vessels into the lesion, when compared with the SC-ECM hydrogel alone. In conclusion, both ECM hydrogels bridged the lesion cavity, modulated the innate immune response, and provided the benefit of a stimulatory substrate for in vivo neural tissue regeneration. However, fast hydrogel degradation might be a limiting factor for the use of native ECM hydrogels in the treatment of acute SCI.

See more in PubMed

Young W. Spinal cord regeneration. Cell Transplant 23, 573, 2014 PubMed

Pego A.P., Kubinova S., Cizkova D., Vanicky I., Mar F.M., Sousa M.M., and Sykova E. Regenerative medicine for the treatment of spinal cord injury: more than just promises? J Cell Mol Med 16, 2564, 2012 PubMed PMC

Kumar P., Choonara Y.E., Modi G., Naidoo D., and Pillay V. Multifunctional therapeutic delivery strategies for effective neuro-regeneration following traumatic spinal cord injury. Curr Pharm Des 21, 1517, 2015 PubMed

Kubinova S., and Sykova E. Biomaterials combined with cell therapy for treatment of spinal cord injury. Regen Med 7, 207, 2012 PubMed

Assuncao-Silva R.C., Gomes E.D., Sousa N., Silva N.A., and Salgado A.J. Hydrogels and cell based therapies in spinal cord injury regeneration. Stem Cells Int 2015, 948040, 2015 PubMed PMC

Macaya D., and Spector M. Injectable hydrogel materials for spinal cord regeneration: a review. Biomed Mater 7, 012001, 2012 PubMed

Siebert J.R., Eade A.M., and Osterhout D.J. Biomaterial approaches to enhancing neurorestoration after spinal cord injury: strategies for overcoming inherent biological obstacles. Biomed Res Int 2015, 752572, 2015 PubMed PMC

Ricks C.B., Shin S.S., Becker C., and Grandhi R. Extracellular matrices, artificial neural scaffolds and the promise of neural regeneration. Neural Regen Res 9, 1573, 2014 PubMed PMC

Crapo P.M., Medberry C.J., Reing J.E., Tottey S., van der Merwe Y., Jones K.E., and Badylak S.F. Biologic scaffolds composed of central nervous system extracellular matrix. Biomaterials 33, 3539, 2012 PubMed PMC

Badylak S.F. Decellularized allogeneic and xenogeneic tissue as a bioscaffold for regenerative medicine: factors that influence the host response. Ann Biomed Eng 42, 1517, 2014 PubMed

Badylak S.F., Freytes D.O., and Gilbert T.W. Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater 5, 1, 2009 PubMed

Nakayama K.H., Lee C.C., Batchelder C.A., and Tarantal A.F. Tissue specificity of decellularized rhesus monkey kidney and lung scaffolds. PLoS One 8, e64134, 2013 PubMed PMC

Adam Young D., Bajaj V., and Christman K.L. Award winner for outstanding research in the PhD category, 2014 Society for Biomaterials annual meeting and exposition, Denver, Colorado, April 16–19, 2014: decellularized adipose matrix hydrogels stimulate in vivo neovascularization and adipose formation. J Biomed Mater Res A 102, 1641, 2014 PubMed

Reing J.E., Zhang L., Myers-Irvin J., Cordero K.E., Freytes D.O., Heber-Katz E., Bedelbaeva K., McIntosh D., Dewilde A., Braunhut S.J., and Badylak S.F. Degradation products of extracellular matrix affect cell migration and proliferation. Tissue Eng Part A 15, 605, 2009 PubMed

Badylak S.F., and Gilbert T.W. Immune response to biologic scaffold materials. Semin Immunol 20, 109, 2008 PubMed PMC

Zhang X.Y., Xue H., Liu J.M., and Chen D. Chemically extracted acellular muscle: a new potential scaffold for spinal cord injury repair. J Biomed Mater Res 100, 578, 2011 PubMed

Li C., Zhang X., Cao R., Yu B., Liang H., Zhou M., Li D., Wang Y., and Liu E. Allografts of the acellular sciatic nerve and brain-derived neurotrophic factor repair spinal cord injury in adult rats. PLoS One 7, e42813, 2012 PubMed PMC

Liu J., Chen J., Liu B., Yang C., Xie D., Zheng X., Xu S., Chen T., Wang L., Zhang Z., Bai X., and Jin D. Acellular spinal cord scaffold seeded with mesenchymal stem cells promotes long-distance axon regeneration and functional recovery in spinal cord injured rats. J Neurol Sci 325, 127, 2012 PubMed

Medberry C.J., Crapo P.M., Siu B.F., Carruthers C.A., Wolf M.T., Nagarkar S.P., Agrawal V., Jones K.E., Kelly J., Johnson S.A., Velankar S.S., Watkins S.C., Modo M., and Badylak S.F. Hydrogels derived from central nervous system extracellular matrix. Biomaterials 34, 1033, 2013 PubMed PMC

DeQuach J.A., Yuan S.H., Goldstein L.S., and Christman K.L. Decellularized porcine brain matrix for cell culture and tissue engineering scaffolds. Tissue Eng Part A 17, 2583, 2011 PubMed PMC

Wolf M.T., Daly K.A., Brennan-Pierce E.P., Johnson S.A., Carruthers C.A., D'Amore A., Nagarkar S.P., Velankar S.S., and Badylak S.F. A hydrogel derived from decellularized dermal extracellular matrix. Biomaterials 33, 7028, 2012 PubMed PMC

Torres-Espin A., Santos D., Gonzalez-Perez F., del Valle J., and Navarro X. Neurite-J: an image-J plug-in for axonal growth analysis in organotypic cultures. J Neurosci Methods 236, 26, 2014 PubMed

Basso D.M., Beattie M.S., and Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12, 1, 1995 PubMed

Crapo P.M., Tottey S., Slivka P.F., and Badylak S.F. Effects of biologic scaffolds on human stem cells and implications for CNS tissue engineering. Tissue Eng Part A 20, 313, 2014 PubMed PMC

Tottey S., Corselli M., Jeffries E.M., Londono R., Peault B., and Badylak S.F. Extracellular matrix degradation products and low-oxygen conditions enhance the regenerative potential of perivascular stem cells. Tissue Eng Part A 17, 37, 2011 PubMed PMC

Valentin J.E., Stewart-Akers A.M., Gilbert T.W., and Badylak S.F. Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds. Tissue Eng Part A 15, 1687, 2009 PubMed PMC

Brown B.N., Ratner B.D., Goodman S.B., Amar S., and Badylak S.F. Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine. Biomaterials 33, 3792, 2012 PubMed PMC

Sicari B.M., Dziki J.L., Siu B.F., Medberry C.J., Dearth C.L., and Badylak S.F. The promotion of a constructive macrophage phenotype by solubilized extracellular matrix. Biomaterials 35, 8605, 2014 PubMed

Slivka P.F., Dearth C.L., Keane T.J., Meng F.W., Medberry C.J., Riggio R.T., Reing J.E., and Badylak S.F. Fractionation of an ECM hydrogel into structural and soluble components reveals distinctive roles in regulating macrophage behavior. Biomater Sci 2, 1521, 2014 PubMed

Cheng H., Liu X., Hua R., Dai G., Wang X., Gao J., and An Y. Clinical observation of umbilical cord mesenchymal stem cell transplantation in treatment for sequelae of thoracolumbar spinal cord injury. J Transl Med 12, 253, 2014 PubMed PMC

Brown R.A. In the beginning there were soft collagen-cell gels: towards better 3D connective tissue models? Exp Cell Res 319, 2460, 2013 PubMed

Sosa I., Reyes O., and Kuffler D.P. Immunosuppressants: neuroprotection and promoting neurological recovery following peripheral nerve and spinal cord lesions. Exp Neurol 195, 7, 2005 PubMed

Kubinova S., Horak D., Hejcl A., Plichta Z., Kotek J., Proks V., Forostyak S., and Sykova E. SIKVAV-modified highly superporous PHEMA scaffolds with oriented pores for spinal cord injury repair. J Tissue Eng Regen Med 9, 1298, 2013 PubMed

Kubinova S., Horak D., Hejcl A., Plichta Z., Kotek J., and Sykova E. Highly superporous cholesterol-modified poly(2-hydroxyethyl methacrylate) scaffolds for spinal cord injury repair. J Biomed Mater Res 99, 618, 2011 PubMed

Cloud B.A., Ball B.G., Chen B.K., Knight A.M., Hakim J.S., Ortiz A.M., and Windebank A.J. Hemisection spinal cord injury in rat: the value of intraoperative somatosensory evoked potential monitoring. J Neurosci Methods 211, 179, 2012 PubMed PMC

Fouad K., Hurd C., and Magnuson D.S. Functional testing in animal models of spinal cord injury: not as straight forward as one would think. Front Integr Neurosci 7, 85, 2013 PubMed PMC

Find record

Citation metrics

Archiving options